•Yiyi Fuzi Baijiang formula protects against DSS-induced colitis by orchestrating the gut barrier-microbiota-metabolism axis
•Ocrelizumab-induced colitis acutely managed with ciclosporin
•International survey of expert practice patterns in the diagnosis and management of adult intestinal failure-associated liver disease
•Reduced fecal GP2 levels in ulcerative colitis associate with inflammatory activity and microbial composition
•Subcutaneous infliximab in pediatric inflammatory bowel disease: Sustained remission, predictable pharmacokinetics, and real-world US implementation
